US-based Inogen, a medical technology company which develops oxygen therapy equipment, and which is backed by Denmark-based drugs company Novo, has filied for an IPO and intends to raise $86m from the offering. No pricing terms have been disclosed. Inogen will trande the stock on the NASDAQ under the ticker symbol “INGN.
In 2009 Inogen raised $3.1m, according to a Securities and Exchange Commission filing. In 2007, Inogen raised $12.7m and $27.6m, according to two different filings. In 2006 it said it had raised $9.5m of a planned $14.5m, as well as raising $7m, according to two different filings. In 2004 the company said it had raised $5.9m, in another filing.
J.P. Morgan will serve as lead underwriter for the offering.